Goldman Sachs Knock-Out LLY/ DE000GG2XMP6 /
5/31/2024 9:58:33 PM | Chg.+0.55 | Bid10:00:36 PM | Ask10:00:36 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
15.66EUR | +3.64% | - Bid Size: - |
- Ask Size: - |
Eli Lilly and Co | 650.7103 USD | 12/31/2078 | Call |
GlobeNewswire
5/30
Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire
5/30
Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire
5/24
Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
GlobeNewswire
5/16
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire
5/16
Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire
5/13
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/13
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire
5/8
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire
5/8
Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire
5/1
H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
GlobeNewswire
4/30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
4/30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
4/29
Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s...
GlobeNewswire
4/26
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorecta...
GlobeNewswire
4/22
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting